OBJECTIVE: Previous reports suggest an increased susceptibility of diabetes patients to infections, but little information is available on possible underlying immunologic dysfunctions. The aim of this study was to evaluate humoral factors in pediatric patients with type 1 diabetes mellitus. METHODS: There were 66 diabetic patients (39 males:27 females; 5-17 yr) classified into two groups according to levels of glycohemoglobin (limit 9%): Group C - controlled (n = 33) and Group UC - uncontrolled (n = 33). We evaluated five patients in C and six in UC who reported previous infections. Immunologic analysis included measurement of plasma concentrations of immunoglobulins (Ig), C3, and C4 levels (turbidimetry); functional hemolytic assays for complement evaluation (CPH for classical and APH for alternative pathways), quantification of C4 isotypes C4A and C4B (ELISA), phagocytosis assays, measurement of bactericidal activity against Staphylococcus aureus, as well as tests of fungicidal capacity for Candida albicans. RESULTS: The UC Group had higher mean age, received higher insulin doses, and had higher concentrations of glycohemoglobin than the C Group. No significant differences in duration of the disease or nutritional conditions were detected between the groups. Lower IgA values in C (10/33) and lower IgG levels in UC (23/33) were detected, and there were inverse relationship with HbA1c values. Analysis of CPH, APH, C3, and C4 showed normal levels in both groups and no statistical correlation with the HbA1c. However, 9/33 children of the UC Group had decreased C3 values. C4B levels were below the normal range in 8/20 and correlated with higher HbA1c. Both phagocytic assays for S. aureus and Candida albicans were within normal limits. CONCLUSIONS: Low IgG concentrations and to some degree reduction in C4B levels were related to impaired metabolic control. No strong link between the immunological alterations was found in diabetic patients and the occurrence of infections.
OBJECTIVE: Previous reports suggest an increased susceptibility of diabetespatients to infections, but little information is available on possible underlying immunologic dysfunctions. The aim of this study was to evaluate humoral factors in pediatric patients with type 1 diabetes mellitus. METHODS: There were 66 diabeticpatients (39 males:27 females; 5-17 yr) classified into two groups according to levels of glycohemoglobin (limit 9%): Group C - controlled (n = 33) and Group UC - uncontrolled (n = 33). We evaluated five patients in C and six in UC who reported previous infections. Immunologic analysis included measurement of plasma concentrations of immunoglobulins (Ig), C3, and C4 levels (turbidimetry); functional hemolytic assays for complement evaluation (CPH for classical and APH for alternative pathways), quantification of C4 isotypes C4A and C4B (ELISA), phagocytosis assays, measurement of bactericidal activity against Staphylococcus aureus, as well as tests of fungicidal capacity for Candida albicans. RESULTS: The UC Group had higher mean age, received higher insulin doses, and had higher concentrations of glycohemoglobin than the C Group. No significant differences in duration of the disease or nutritional conditions were detected between the groups. Lower IgA values in C (10/33) and lower IgG levels in UC (23/33) were detected, and there were inverse relationship with HbA1c values. Analysis of CPH, APH, C3, and C4 showed normal levels in both groups and no statistical correlation with the HbA1c. However, 9/33 children of the UC Group had decreased C3 values. C4B levels were below the normal range in 8/20 and correlated with higher HbA1c. Both phagocytic assays for S. aureus and Candida albicans were within normal limits. CONCLUSIONS: Low IgG concentrations and to some degree reduction in C4B levels were related to impaired metabolic control. No strong link between the immunological alterations was found in diabeticpatients and the occurrence of infections.
Authors: Chester A Alper; Zaheed Husain; Charles E Larsen; Devendra P Dubey; Rosanne Stein; Caitlin Day; Alissa Baker; Huriya Beyan; Mohammed Hawa; Thomas O Ola; R David Leslie Journal: J Autoimmun Date: 2006-10-06 Impact factor: 7.094
Authors: Philipp Schuetz; Alan E Jones; Michael D Howell; Stephen Trzeciak; Long Ngo; John G Younger; William Aird; Nathan I Shapiro Journal: Ann Emerg Med Date: 2011-06-16 Impact factor: 5.721
Authors: Philipp Schuetz; Natalie Friedli; Eva Grolimund; Alexander Kutz; Sebastian Haubitz; Mirjam Christ-Crain; Robert Thomann; Werner Zimmerli; Claus Hoess; Christoph Henzen; Beat Mueller Journal: Diabetologia Date: 2013-11-24 Impact factor: 10.122
Authors: Sabine Abke; Markus Neumeier; Johanna Weigert; Gabriele Wehrwein; Elke Eggenhofer; Andreas Schäffler; Kevin Maier; Charalampos Aslanidis; Jürgen Schölmerich; Christa Buechler Journal: Cardiovasc Diabetol Date: 2006-08-30 Impact factor: 9.951
Authors: Gabriele Wehrwein; Markus Neumeier; Andreas Schäffler; Andrea Kopp; Johanna Weigert; Sabine Abke; Jürgen Schölmerich; Christa Buechler Journal: Cardiovasc Diabetol Date: 2006-03-27 Impact factor: 9.951
Authors: Ingrid Lea Scully; Lisa Kristin McNeil; Sudam Pathirana; Christine Lee Singer; Yongdong Liu; Stanley Mullen; Douglas Girgenti; Alejandra Gurtman; Michael W Pride; Kathrin Ute Jansen; Paul L Huang; Annaliesa S Anderson Journal: Diabetol Metab Syndr Date: 2017-10-03 Impact factor: 3.320